JTCS Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Shigeki Morita
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanoue, Y.
Right arrow Articles by Yasui, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanoue, Y.
Right arrow Articles by Yasui, H.

J Thorac Cardiovasc Surg 1999;118:547-556
© 1999 Mosby, Inc.


CARDIOTHORACIC TRANSPLANTATION

NITROGLYCERIN AS A NITRIC OXIDE DONOR ACCELERATES LIPID PEROXIDATION BUT PRESERVES VENTRICULAR FUNCTION IN A CANINE MODEL OF ORTHOTOPIC HEART TRANSPLANTATION

Yoshihisa Tanoue, MD, Shigeki Morita, MD, Yoshie Ochiai, MD, Naho Haraguchi, MD, Ryuji Tominaga, MD, Yoshito Kawachi, MD, Hisataka Yasui, MD

From The Department of Cardiovascular Surgery, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Presented in part at the Sixty-ninth Scientific Sessions of the American Heart Association, New Orleans, Louisiana, November 10-13, 1996, and published in abstract form (Circulation 1996; 94[Suppl]:I53).

Address for reprints: Shigeki Morita, MD, Department of Cardiovascular Surgery, Faculty of Medicine, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan (E-mail:morita{at}heart.med.kyushu-u.ac.jp).

Background: Nitric oxide has cardioprotective effects through several mechanisms. However, nitric oxide may have deleterious effects in the presence of superoxide because it is converted to peroxynitrite, which then initiates lipid peroxidation. Using a canine model of orthotopic heart transplantation, we examined whether adding an organic nitric oxide donor, nitroglycerin, to preservation solution elicits lipid peroxidation after reperfusion and causes deleterious effects on coronary endothelial function and left ventricular function.
Methods and results: The donor heart was preserved for 24 hours in cold University of Wisconsin solution with nitroglycerin (0.1 mg/mL) supplementation (group NTG, n = 8) or in standard University of Wisconsin solution (group C, n = 8). After reperfusion, changes of coronary resistance were measured during the infusion of acetylcholine (0.1 mg/min) and of sodium nitroprusside (1 mg/min), and percent coronary relaxation was calculated. Left ventricular function was evaluated by pressure-volume relations with the use of a conductance catheter, thereby deriving the slopes of end-systolic pressure-volume relation, stroke work–end-diastolic volume relation, and maximum rate of change of left ventricular pressure–end-diastolic volume relation. Serum lipid peroxide level was measured. Percent coronary relaxation was similar for the 2 groups. The slopes of end-systolic pressure-volume relation, stroke work–end-diastolic volume relation, and maximum rate of change of left ventricular pressure–end-diastolic volume relation in group NTG were significantly higher than those in group C. On the other side, serum lipid peroxide level in group NTG was significantly higher than that in group C.
Conclusions: Nitroglycerin may have detrimental effects evidenced by the increase in lipid peroxidation, which implied peroxynitrite formation. However, the overall effect of nitroglycerin was cardioprotective. Although the exact mechanism is yet to be clarified, the superb cardioprotective effect of nitroglycerin overwhelms the exaggeration of lipid peroxidation.




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
N. Kajihara, S. Morita, Y. Tanoue, N. Boku, M. Eto, T. Nishida, and R. Tominaga
The UW solution has greater potential for longer preservation periods than the Celsior solution: comparative study for ventricular and coronary endothelial function after 24-h heart preservation.
Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 784 - 789.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
Y. Oishi, Y. Nishimura, K.-i. Imasaka, N. Kajihara, S. Morita, M. Masuda, and H. Yasui
Impairment of coronary flow reserve and left ventricular function in the brain-dead canine heart
Eur. J. Cardiothorac. Surg., September 1, 2003; 24(3): 404 - 410.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Tanoue, P. Herijgers, B. Meuris, E. Verbeken, V. Leunens, M. Lox, and W. Flameng
Ischemic preconditioning reduces unloaded myocardial oxygen consumption in an in-vivo sheep model*
Cardiovasc Res, August 15, 2002; 55(3): 633 - 641.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Tanoue, A. Sese, Y. Ueno, K. Joh, and T. Hijii
Bidirectional Glenn Procedure Improves the Mechanical Efficiency of a Total Cavopulmonary Connection in High-Risk Fontan Candidates
Circulation, May 1, 2001; 103(17): 2176 - 2180.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1999 by The American Association for Thoracic Surgery.